jeudi 17 décembre 2015

Onco Actu du 17 décembre 2015


1. Biologie

Researchers take first step in precision medicine for penile cancer [University of Michigan Health System]

Scientists discover how cancer cells escape blood vessels [MIT News]

2. Etiologie

Cancer is not just 'bad luck' but down to environment, study suggests [BBC News]

Cancer studies clash over mechanisms of malignancy [Nature News & Comment]

Most cancers due to 'bad luck'? Not so fast, says study [STAT]

Cancer: More than just bad luck? [LA Times]

Most cases of cancer are avoidable, say researchers [The Guardian]


Nine in 10 cancers caused by lifestyle [The Telegraph]

3.1 Tabac

Active and secondhand smoking both linked to early menopause [NHS Choices]

3.3 Prévention - Vaccins

FDA Approves Expanded Age Indication for GARDASIL® 9 in Males [Merck]

4. Dépistage, diagnostic et pronostic

Why Human Genetics Research Is Full of Costly Mistakes [The Atlantic]



The science myths that will not die [Nature News & Comment]

4.12 Biopsies liquides

UK scientists develop new method to diagnose and monitor rare childhood cancer [Cancer Research UK]

5. Traitements

Harnessing chemical and genomic data to fight cancer [Broad Institute of MIT and Harvard]

5.10 Traitements - Essais

Clinical Trials: NIH and the Drug Industry [In the Pipeline]

5.2 Pharma

Array's melanoma drug clears Phase III with an FDA filing in sight [FierceBiotech]

Novartis hires Harvard star to plug gaps in cancer drug arsenal [Reuters]

Array BioPharma cancer drug succeeds in late-stage study [Reuters]

Array BioPharma Announces Phase 3 Binimetinib Trial Meets Primary Endpoint For NRAS-Mutant Melanoma [Array BioPharma]

5.2.1 Pharma - Partenariats

With Pierre Fabre Deal, Cellectar Shifts Strategy Under New CEO [Xconomy]

5.3 Traitements - FDA, EMA,...

FDA lifts clinical hold on Advaxis' cancer compounds [Reuters]

5.4 Traitements - Economie

Bristol's drug pricing under fire as UK agency rejects Opdivo [Reuters]

Even with smaller ‘donut hole,’ Medicare cancer pill costs stay high [Reuters]

5.7.1 SABCS-communiqués

New "Big Data" Brings Total Number of Breast Cancer Patients Studied to 50,000, Demonstrating Oncotype DX® Accurately Predicts Clinical Outcomes [Genomic Health]

5.7.2 SABCS-divers

Buparlisib May be a BELLE Only for Select Patients [The OBR Blog]

6. Lutte contre les cancers

Eminent Cancer Researcher Dies [The Scientist]

6.8 Communication

Opdivo commercial vs. the reality of stage IV cancer treatment [HealthNewsReview]